Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Solid Tumor|Lymphoma
Interventions: DRUG: oral belinostat
Sponsor: Valerio Therapeutics
Collaborators: Spectrum Pharmaceuticals, Inc